The half-life of truth: What are appropriate time horizons for research decisions?

Medical Decision Making

Volumn 28, Issue 3, 2008, Pages 287-299

  Philips, Zoe ^a,b   Claxton, Karl ^a   Palmer, Stephen ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Priority setting; Research decisions; Value of information

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DECISION MAKING; EMPIRICISM; INFORMATION; INTERPERSONAL COMMUNICATION; MATHEMATICAL COMPUTING; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; OUTCOME ASSESSMENT; POPULATION; QUALITY ADJUSTED LIFE YEAR; REVIEW;

DECISION MAKING; MODELS, STATISTICAL; RESEARCH; RESEARCH DESIGN; TIME FACTORS;

EID: 44049098205     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X07312724     Document Type: Review

References (29)

1. Claxton K. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. J Health Econ 1999 ; 18: 324-64.
2. Pratt J., Raiffa H., Schlaiffer R. Statistical Decision Theory. Cambridge (MA): MIT Press ; 1995.
3. Raiffa H., Schlaifer R. Applied Statistical Decision Theory. Cambridge (MA): Division of Research, Graduate School of Business Administration, Harvard University ; 1961.
4. Raiffa H. Decision Analysis: Introductory Lectures on Choices under Uncertainty. New York: Addison-Wesley ; 1968.
5. Howard R. Information value theory. IEEE Trans Syst Sci Cybernet 1966 ; SSC2: 122-6.
6. Thompson K., Evans J. The value of improved national exposure to information for perchloroethylene (perc): a case study for dry cleaners. Risk Anal 1997 ; 17: 253-71.
7. Thompson K., Graham J. Going beyond the single number: using probabilistic risk assessment to improve risk management. Hum Ecol Risk Assess 1996 ; 2: 1008-34.
8. Hammitt J., Cave J. Research Planning for Food Safety: A Value of Information Approach. Santa Monica (CA): RAND; 1991.
9. Philips Z., Claxton KP, Palmer S., Bojke L., Sculpher MJ Priority setting for research in health care: an application of value of information analysis to glycoprotein IIb/Illa antagonists in non-ST elevation acute coronary syndrome. Int J Technol Assess Health Care 2006 ; 22 (3). 379-87.
10. Claxton K., Ginnelly L., Sculpher M., Philips Z., Palmer S. A pilot study on the use of decision theory and value of information analysis as part of the NHS Health Technology Assessment programme. Health Technol Assess 2004 ; 8 (31). 1-103.
11. Claxton K., Eggington S., Ginnelly L., et al. A pilot study of using value of information analysis to support research recommendations from the National Institute for Clinical Excellence. Centre for Health Economics Research Paper Series No. 4. London: University of York ; 2005.
12. Claxton K., Sculpher M. Using value of information analysis to prioritize health research: some lessons from recent UK experience. Pharmacoeconomics 2006 ; 24: 1055-68.
13. Stinnett A., Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making 1998 ; 18 (suppl): S68-80.
14. Ades A., Lu G., Claxton K. Expected value of sample information calculations in medical decision modeling. Med Decis Making 2004 ; 24 (2). 207-27.
15. Brennan A., Kharroubi S. Efficient computation of partial expected value of sample information using Bayesian approximation. J Health Econ 2007 ; 26 (1). 122-48.
16. Eckermann S., Willan A. Expected value of information and decision making in HTA. Health Econ 2007 ; 16 (2). 195-209.
17. Tappenden P., Chilcott, Eggington S, Oakley J., McCabe C. Methods for expected value of information analysis in complex health economic models: developments on the health economics of interferon-beta and glatiramer acetate for multiple sclerosis. Health Technol Assess 2004 ; 8 (27). 1-78.
18. Felli J., Hazen G. Sensitivity analysis and the expected value of perfect information. Med Decis Making 1998 ; 18: 95-109.
19. Claxton K., Posnett J. An economic approach to clinical trial design and research priority-setting. Health Econ 1996 ; 5: 513-24.
20. Yokota F., Thompson K. Value of information literature analysis: a review of applications in health risk management. Med Decis Making 2004 ; 24: 287-98.
21. Palmer S., Sculpher M., Philips Z., et al. A cost effectiveness model comparing alternative management strategies for the use of glycoprotein IIb/IIIa antagonists in non ST-elevation acute coronary syndrome. NICE assessment report. 2002. Available from: URL: http://www.nice.org.uk/page.aspx?o=36361.
22. Sculpher M., Claxton K. Establishing the cost-effectiveness of new pharmaceuticals under conditions of uncertainty-when is there sufficient evidence ? Value Health 2005 ; 8: 433-46.
23. Bojke L., et al. The cost-effectiveness and value of information associated with repeat screening for age related macular degeneration. Med Decis Making. In press.
24. Hall J., Platell C. Half-life of truth in surgical literature [Letter]. Lancet. 1997 ; 350: 1752.
25. Poynard T., Munteanu M., Ratziu V., et al. Truth survival in clinical research: an evidence-based requiem? Ann Intern Med 2002. 136: p. 888-895.
26. Briggs A., Claxton K., Sculpher M. Decision Modelling for Health Economic Evaluation. Oxford (UK): Oxford University Press ; 2006.
27. Pirsig R. Zen and the Art of Motorcycle Maintenance. New York: William Morrow ; 1974.
28. Salomon J., Weinstein M., Goldie S. Taking account of future technology in cost effectiveness analysis. BMJ 2004 ; 329 (7468). 733-6.
29. Palmer S., Smith P. Incorporating option values into the economic evaluation of health care technologies. J Health Econ 2000 ; 19: 755-66.